New research suggests that people who come off popular slimming jabs like semaglutide or tirzepatide tend to recover lost weight far faster than those who halt traditional lifestyle programs.
Findings released in a leading health publication demonstrates that while obese people can lose substantial amounts of their body weight while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month after stopping.
"Individuals purchasing such treatments should be aware of the danger of fast weight regain when the medication ends," cautioned expert Dr. Susan Jebb.
This pace of regain suggests a return to original mass within about 18 months.
Comparing Treatments
The research, which looked at dozens of studies involving thousands of patients, compared the outcomes of these new drugs with older methods.
The team note that people who lose weight through dieting typically see a more gradual weight regain—perhaps 100 grams monthly—after stopping.
Explaining the Rapid Rebound
Doctors propose the mode of action of the jabs accounts for the accelerated rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which controls hunger.
"Sustained high doses of the hormone concentrations far above than normal could lead to the body to produce less of its endogenous hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this medication results in hunger is unsuppressed, making excessive eating far more likely."
An Ongoing Issue?
Medical guidelines advise the jabs for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Many experts contend that, considering the high risk of weight regain, the therapy is often ongoing.
This perspective is reinforced by drug manufacturers, who state that the results "underscore the long-term character of obesity," similar to managing conditions like diabetes.
User Accounts
Users who have stopped the medication describe a sudden return of cravings.
"It was like something activating and you're instantly starving," said one woman.
The struggle is worsened if users have not developed sustainable dietary or behavioural changes during treatment.
Growing Use
Figures indicate that millions of adults in the UK have tried these injections in the last 12 months, with interest remaining high.
- Adoption is greater among females than men.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
Finally, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a magic cure and lasting health benefits hinges on integrated lifestyle management.
